DNMT1 and acute myeloid leukemia: As DNMT inhibitors show efficacy in MDS/AML, given the increased global methylation we observed in the ASXL1 mutant KBM5 cells, we next treated the ASXL1 mutant and corrected cells with the DNMT inhibitor AZA.